Cargando…
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
The pace of scientific progress over the past several decades within the biological, drug development, and the digital realm has been remarkable. The’omics revolution has enabled a better understanding of the biological basis of disease, unlocking the possibility of new products such as gene and cel...
Autores principales: | Macdonald, Judith C., Isom, David C., Evans, Daniel D., Page, Katy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183468/ https://www.ncbi.nlm.nih.gov/pubmed/34109196 http://dx.doi.org/10.3389/fmed.2021.660808 |
Ejemplares similares
-
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021) -
Blockchain in surgery: are we ready for the digital revolution?
por: Carrano, Francesco Maria, et al.
Publicado: (2022) -
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
por: Hsieh, Julie, et al.
Publicado: (2022) -
The Importance of the Human Mass Balance Study in Regulatory Submissions
por: Coppola, Paola, et al.
Publicado: (2019) -
Advancing an agile regulatory ecosystem to respond to the rapid development of innovative technologies
por: ElZarrad, M. Khair, et al.
Publicado: (2022)